Stocks · Health care · Pharmaceutical Preparations

ProMIS Neurosciences Inc.

PMN Clue Score53
Ontario, Canada Fiscal year ends December CIK 0001374339 Results filed 13 Aug 2026

What the insiders did Net buying

By person

11 insiders · 2 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Neil Cashman
Chief Scientific Officer
$38.60K (1)
—
+$38.60K
23,440
$90.48K
—
Eugene Williams
Director
$5.25K (1)
—
+$5.25K
13,713
$52.93K
+114.4%
Jeremy M. Sclar 2012 Irrevocable Family Trust entity
10% owner
—
—
—
3,710,459
$14.32M
+129.4%
Jeremy M. Sclar
10% owner
—
—
—
3,710,459
$14.32M
+129.4%
Michael S Gordon
See Remarks section.
—
—
—
2,435,029
$9.40M
+9.8%
19 Promis Title
10% owner
—
—
—
2,435,029
$9.40M
+17.3%
ABG Management Ltd. entity
10% owner
—
—
—
943,090
$3.64M
+289.1%
Patrick D. Kirwin
Director
—
—
—
9,788
$37.78K
+257.5%
Max A. Milbury
Principal Accounting Officer
—
—
—
8,409
$32.46K
—
Johanne Kaplan
Chief Development Officer
—
—
—
6,221
$24.01K
+2,369%
Neil K Warma
Chief Executive Officer
—
—
—
6,183
$23.87K
—

No percentages here. This company's share count has moved by a factor of 6.0 over the window, from 8,967,693 to 53,811,110 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.